U.S. Retail REITs Stock News

NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Can AGNC’s Core Earnings Strength Amid a Net Loss Reframe the Investment Narrative for AGNC (AGNC)?

AGNC Investment Corp. reported first-quarter 2026 results showing a net loss of US$148 million, or US$0.17 loss per share from continuing operations, compared with net income and earnings per share a year earlier. Despite this headline loss, the company’s strong core operating performance, wider net interest spread, and continued dividend record have drawn renewed institutional interest and debate about whether the shares remain undervalued. We’ll now examine how AGNC’s strong core...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Is Solventum (SOLV) Offering Value After Its Recent Spin Off From 3M

Wondering if Solventum at around US$67.51 is offering value or just noise in the healthcare space? This article walks you through what the current price could mean for you. Over the short term, Solventum has seen a 2.1% decline over the last 7 days, a 7.6% return over 30 days, and a 14.6% decline year to date, while the 1 year return sits at 1.9%. Recent coverage of Solventum has focused on its position in the Medical Equipment industry and how investors are reacting to its standalone...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Is It Too Late To Consider CareTrust REIT (CTRE) After Strong Multi Year Gains?

Investors may be wondering if CareTrust REIT at around US$39.71 is offering good value right now, or if the recent excitement has already been priced in. The stock has seen returns of 3.5% over the last 7 days, 6.9% over the last 30 days, 9.4% year to date, 43.6% over 1 year, 136.5% over 3 years and 118.6% over 5 years, which puts recent price moves front and center for any valuation check. Recent news coverage has focused on CareTrust REIT as a health care focused REIT, with attention on...
NYSE:PR
NYSE:PROil and Gas

Is Permian Resources’ (PR) Earnings Beat Streak Hiding a Deeper Operational Edge?

Permian Resources has recently drawn attention after analysts highlighted its strong record of beating earnings expectations and flagged a positive setup for another potential earnings surprise ahead of its early May 2026 quarterly report. This ongoing pattern of outperformance against forecasts is sharpening focus on how effectively the company converts operational execution into consistent earnings resilience. We’ll now examine how this renewed optimism around another possible earnings...
NYSE:KMPR
NYSE:KMPRInsurance

Is Kemper (KMPR) Looking Mispriced After Recent Share Price Weakness?

If you are wondering whether Kemper's current share price fairly reflects the business, the next sections will walk through what the numbers are actually saying about value. The stock last closed at US$33.62, with returns of 2.1% over the past week and 12.4% over the past month, set against a 15.0% decline year to date and a 42.0% decline over the past year. Recent headlines around Kemper have focused on its position in the US insurance space and how the market is reassessing risk and...
NYSE:MCB
NYSE:MCBBanks

A Look At Metropolitan Bank Holding (MCB) Valuation After Strong Q1 Results And Dividend Increase

Metropolitan Bank Holding (MCB) has drawn fresh investor attention after reporting first quarter results that included higher net interest income and net income year over year, along with an increase in its regular quarterly dividend. See our latest analysis for Metropolitan Bank Holding. The latest earnings and dividend announcement have come alongside a 1 month share price return of 12.65% and an 18.03% year to date share price return, while the 3 year total shareholder return is very...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Is It Too Late To Consider Alnylam Pharmaceuticals (ALNY) After Its Strong Multi‑Year Run?

Investors may be wondering whether Alnylam Pharmaceuticals, at around US$302 a share, still offers value or if most of the opportunity has already been priced in. The stock has had a mixed return profile lately, with a 2.7% decline over the last 7 days, a 4.4% decline over 30 days, a 14.8% gain over 1 year, and a 127.7% gain over 5 years, which may have shifted how some investors think about its risk and reward. Recent coverage around the company has focused on its role in the biotech space...
NYSE:SGHC
NYSE:SGHCHospitality

Is Super Group (SGHC) Still Attractive After Its 58% One-Year Share Price Surge

If you are trying to figure out whether Super Group (SGHC) is genuinely good value or just looks that way on the surface, the recent share price action gives you plenty to think about. The stock last closed at US$12.34, with returns of 18.3% over 30 days, 6.0% year to date, and 58.3% over 1 year, while the 7 day return was a modest 0.5% decline. Recent coverage has centered on Super Group's position within the online betting and gaming space and how regulatory developments and competitive...
NYSE:GM
NYSE:GMAuto

GM (GM) Margin Compression To 1.6% Tests Bullish Expansion Narratives

General Motors (GM) opened 2026 with Q1 results that put the focus squarely on profitability, reporting revenue of US$43.6 billion and net income of US$2.6 billion, which translated into basic EPS of US$2.88 for the quarter. Over the past year, the company has seen quarterly revenue move in a tight band between US$43.6 billion and US$48.6 billion, while basic EPS has swung from a quarterly high of US$3.40 to a loss of US$3.60, setting up a sharp contrast between steady top line performance...
NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Baker Hughes Qatar LNG Win Highlights Growing Gas Technology Momentum

Baker Hughes has secured a major contract to supply LNG equipment for Qatar's North Field West expansion. The award ties the company to one of the world's largest LNG projects while Middle East disruptions and supply chain challenges continue. The contract focuses on critical hardware for LNG production, reinforcing demand for Baker Hughes' gas focused technology. Baker Hughes, listed as NasdaqGS:BKR, is drawing new attention as this contract adds to an already active year for its...
NYSE:CNC
NYSE:CNCHealthcare

US Stock Market Today S&P 500 Futures Edge Higher As Fed Decision Looms

The Morning Bull - US Market Morning Update Wednesday, Apr, 29 2026 US stock futures are slightly higher this morning, with E mini S&P 500 and Nasdaq 100 contracts edging up as investors wait for the Federal Reserve’s April meeting. The Fed is widely expected to keep its main interest rate unchanged, which effectively decides how expensive mortgages, credit cards and business loans feel. At the same time, the 10 year US Treasury yield is sitting near 4.35% while oil inventories fell by about...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

A Look At GE HealthCare (GEHC) Valuation As Mangaciclanol Fast Track Trial Progresses

GE HealthCare Technologies (GEHC) has kicked off its international Phase 2/3 LUMINA trial, dosing the first patient with mangaciclanol, a manganese based MRI contrast agent that has been granted FDA Fast Track status. See our latest analysis for GE HealthCare Technologies. The latest product and AI partnerships are arriving at a time when momentum has softened, with a 1 day share price return of 2.81% decline, a 90 day share price return of 13.58% decline, and a 1 year total shareholder...
NasdaqGS:AAL
NasdaqGS:AALAirlines

American Airlines Rejects Mega Merger Talk As Governance Questions Loom

American Airlines Group (NasdaqGS:AAL) publicly rejected rumors of a mega merger with United Airlines, stating such a deal would be harmful for competition and consumers. The company addressed the speculation directly in a rare, categorical statement, signaling clear opposition to large scale industry consolidation. At its upcoming AGM, American Airlines faces activist shareholder proposals related to voting processes, officer liability limits and other governance topics. The company is also...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

How Synaptics’ Edge AI and IoT Momentum Could Reframe Synaptics (SYNA) Investors’ Narrative

In recent weeks, Synaptics has highlighted progress in its Edge AI push, including the Astra processor family developed with Google Research and early customer uptake, alongside strong Core IoT segment growth and new engagement with a major humanoid robotics client. This combination of native on-device AI capabilities and expanding IoT design wins signals a meaningful shift in Synaptics’ role within next-generation connected devices. Next, we’ll examine how Synaptics’ Astra Edge AI launch...
NYSE:COUR
NYSE:COURConsumer Services

Coursera (COUR) Valuation Check After Q1 Earnings, Revenue Guidance And Reaffirmed 2026 Outlook

Q1 earnings and guidance set the tone Coursera (COUR) reported first quarter 2026 results with sales of US$195.7 million and a net loss of US$20.5 million, while also issuing second quarter revenue guidance and reaffirming its full year 2026 outlook. See our latest analysis for Coursera. The Q1 earnings release and reaffirmed 2026 revenue outlook arrived alongside a sharp 11.7% 1 day share price return to US$6.49. However, Coursera’s 1 year total shareholder return of 23.01% decline and 5...
NYSE:PM
NYSE:PMTobacco

Philip Morris Backs Veteran Entrepreneurs To Broaden U.S. Investment Narrative

Philip Morris International (NYSE:PM) has committed a $30,000 donation to the Acadiana Veteran Alliance in the U.S. The funding supports veteran entrepreneurs and local business formation as part of a broader corporate citizenship approach. This initiative reflects an expansion of the company’s U.S. engagement beyond smoke free products and related messaging. For investors tracking Philip Morris International at a current share price of $165.89, this move adds another piece to the overall...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher Refocuses On Biopharma With Microbiology Sale And New Center

Thermo Fisher Scientific (NYSE:TMO) agreed to sell its microbiology business to Astorg for more than US$1b. The transaction reflects a shift in focus away from specialty diagnostics toward biopharma services and biologics. The company also opened a new U.S. Bioprocess Design Center aimed at supporting biologics development and manufacturing. For you as an investor, these moves highlight where Thermo Fisher Scientific, a major player in life science tools and diagnostics, is choosing to...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Is Strong FCF Growth From AI and Auto Tailwinds Altering The Investment Case For Monolithic Power Systems (MPWR)?

In recent updates, Monolithic Power Systems has been highlighted for about 27% annual revenue growth over five years, expanding free cash flow margins, and a return on invested capital of 43.5%, while analysts previously anticipated its upcoming quarterly report would show earnings of US$4.89 per share on US$781.1 million in revenue, both increasing from a year earlier. This combination of strong historical execution and expectations for higher near-term earnings has intensified investor...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Assessing Fastly (FSLY) Valuation After Earnings Anticipation And New LaLiga AI Partnership

Fastly (FSLY) jumped 8.59% after a three-day slide, as investors reacted to its upcoming first quarter earnings release and a new LaLiga partnership that uses AI to tackle live sports piracy and illegal streaming. See our latest analysis for Fastly. That rebound comes after a softer near term patch, with a 1 day share price return of 4.53% decline, 7 day return of 2.22% decline and 30 day return of 3.49% decline. This is set against a much stronger backdrop of a 90 day share price return of...
NYSE:DLR
NYSE:DLRSpecialized REITs

Is It Too Late To Consider Digital Realty Trust (DLR) After Its Strong AI Driven Rally?

If you are wondering whether Digital Realty Trust is still reasonably priced after its strong run, a good starting point is understanding how its current share price lines up against different measures of value. The stock recently closed at US$194.58, with returns of 10.9% over 30 days, 25.5% year to date and 25.3% over 1 year. This naturally raises questions about how much optimism is already reflected in the price. Recent headlines have centered on Digital Realty Trust's role as a key...
NYSE:MCK
NYSE:MCKHealthcare

Is It Time To Reassess McKesson (MCK) After Its Strong Multi Year Share Price Run

Wondering if McKesson at around US$835 a share still offers value after a strong multi year run? This piece breaks down what the current price might be telling you. The stock has been relatively steady in the short term, with a 0.9% decline over 7 days and a 2.9% decline over 30 days, while sitting on a 1.4% return year to date and an 18.5% return over the last year, compared with a very large gain over 5 years. Recent headlines have focused on McKesson's role in the broader healthcare...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

What Opera (OPRA)'s Q1 Earnings Beat and AI-Powered Browser Push Mean For Shareholders

Opera Limited has already reported its first-quarter 2026 results, posting revenue of US$175.77 million and net income of US$24.79 million, with both basic and diluted earnings per share from continuing operations at US$0.27, above the prior-year period. Beyond the headline numbers, Opera outperformed its own guidance, driven by record advertising revenue, growing MiniPay wallet engagement, and new AI-powered browser features that prompted management to lift full-year expectations while...
NYSE:HPE
NYSE:HPETech

A Look At Hewlett Packard Enterprise (HPE) Valuation As Earnings Optimism And Goldman Sachs Support Lift Interest

Why Hewlett Packard Enterprise (HPE) is in focus right now Hewlett Packard Enterprise (HPE) is back on watchlists after a recent share price move tied to optimism ahead of its upcoming Q2 earnings report and fresh positive commentary from Goldman Sachs. See our latest analysis for Hewlett Packard Enterprise. Despite a 2.3% 1 day share price decline and a 2.8% 7 day share price pullback, HPE’s recent 16.8% 30 day and 28.7% 90 day share price returns, together with a 1 year total shareholder...